Table: Sapporo Clinical Lab - 6-MTH group results

Sapporo Clinical Laboratory

09/11/2020 06:30

Nov 9 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2020        Sep 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             8.36                8.84             17.23    
                 (-5.4 pct)          (+4.8 pct)       (-2.5 pct)  
  Operating        368 mln             492 mln          620 mln   
                 (-25.2 pct)         (+54.7 pct)      (-34.3 pct) 
  Recurring        376 mln             508 mln          635 mln   
                 (-25.9 pct)         (+53.8 pct)      (-35.4 pct) 
  Net              225 mln             326 mln          407 mln   
                 (-30.8 pct)         (+57.7 pct)      (-22.9 pct) 
  EPS             65.88 yen           95.25 yen       119.03 yen  
  Ann Div                             10.00 yen        10.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             10.00 yen        10.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T